SlideShare ist ein Scribd-Unternehmen logo
1 von 53
PHARMACEUTICAL MICROBIOLOGY (BP303T)
Unit-IV
Part-1
Designing of aseptic area, laminar flow equipment: Study of
different source of contamination in aseptic area and methods
of prevention, clean area classification.
Name: Ms. Pooja Deepak Bhandare
Assistant Professor
G H RAISONI UNIVERSITY
SCHOOL OF PHARMACY
Introduction:
• Production of sterile products is carried out in a clean area which has strictly
controlled environmental quality of air particles, microbial contamination.
• Some pharmaceutical products are not terminally sterilized (Packed, Sealed and
Sterilized) such products are meant to be prepared from sterile ingredients and are
sterilized by filtration before packing in sterile containers.
• For manufacturing of such products strict aseptic measures need to be followed and
hence as Aseptic Area becomes an essential part of such manufacturing units.
• An aseptic area is a premise in a clean area, designed, constructed, serviced and used
with an intention to prevent the microbial contamination of the product
• Aseptic techniques are employed to provide protection to ophthalmic
and parenteral products by preventing the entry of microbial and
particulate contamination.
• Prevention of microbial contamination is also required to remove
pyrogens and toxic bacterial products. The terminally sterilised products
(product sealed in container and then sterilised) are prepared in clean
areas: while products not terminally sterilised are prepared under aseptic
conditions using sterile materials or are sterilised by filtration before
being packed in sterile containers.
• Such aseptic products are formulated or prepared in an aseptic area, which is a
room within a clean area designed, constructed, serviced, and used for
controlling and preventing microbial contamination of the product.
• Like sterile medicinal products, vaccines containing dead microorganisms,
microbial extracts, or inactivated viruses are also filled in aseptic areas; while
live or attenuated vaccines are filled in separate areas.
• The sterile production unit and the general manufacturing area within the
hospital pharmacy or factory should be located separately.
• The sterile production unit should be restricted, i.e., unauthorised personnel
should not gain access to this unit.
Designing of Aseptic Area
• Production of sterile products should be carried out in a clean
environment with a limit for the environmental quality of microbial and
dust particle contamination. • This limit for contamination is necessary to
reduce the product contamination.
• The production area is normally divided into
• i) The clean-up area,
• ii) The compounding area,
• iii) The aseptic area,
• iv) The quarantine area and
• v) The packaging/labelling area.
• Flow diagram of aseptic area
1. Clean-up section
• The cleaning area has walls and ceilings made up of film coating
materials.
• Air inside the clean area should be free from dust and microorganisms.
• This is ensured through high efficiency (95%) filters.
• Air existing in the clean area should be frequently replace (10-15 air
changes per hour).
2. Compounding section
• This area contains stainless steel cabinets and counters and is involved
in the actual compounding.
• Unlike aseptic area, maintenance of sterile conditions is not essential,
but necessary measures should be adopted to control the dust
generated from raw material during weighing and compounding.
3.Aseptic area
• In this area, strict control measures should be adopted to avoid
contamination of the preparations.
• The stainless steel counters and cabinets should be such that they should
not allow dirt particles to accumulate.
• Mixing and storage of the compounded preparations should be done
outside the aseptic area.
• The compounded preparations are then transferred to the aseptic area
through pipelines where the filling operation is carried out.
4. Quarantine section
• This area consists of a store where the in process batches as well as
approved batches are stored separately.
• This area has limited access and is under the control of a responsible
person.
• Without the consent of the in charge, other personnel cannot enter into
this particular area.
5. Packing and labelling section
• In this area, the batches are packed and labelled.
• Packing is carried out by packaging machines, while labels are obtained by
over printing devices.
• At a time, only one product labels are printed.
• Parenteral packing plays a vital role in the production of sterile
preparations.
• Packing should be carried out in such a manner that the sterility of the
product is maintained.
Floors, walls and ceilings
• All clean surfaces including the floor, walls and ceilings must be smooth, easy to
clean, disinfected and be constructed to minimize microbial and particulate
contamination.
• Flexing and non-flexing types of materials are used for construction of floor.
• Flexing floor materials are made up of synthetic elastromers of which most
commonly used are polyvinylchloride (PVC). PVC flooring is easily repaired,
cleaned, relatively cheap and simple.
• Non-flexing floors are made of hard inorganic filler substances in a matrix
material.
• Walls must be made up of non-inflammable or fire resistant material e.g: Stainless
steel, glass, enamelled steel, etc.
• Generally plaster walls are easily damaged by the impact.
• For reduction of fungal growth , 1% of 8- hydroxyquinolone, pentachlorophenol,
etc may be added to the paint.
• Epoxy resin paints and polyurethane paints are also used to avoid cracking and
peeling.
• The ceilings are sealed to prevent the entry of microbial contaminants.
• Internal fittings such as a cupboards, drawers, shelves, and equipment's must be
kept to a minimum.
Doors, windows and services
• Doors and windows should fit flush with the walls. Windows if required, are solely to
provide illumination and are not for ventilation.
• Windows should be non-open able.
• Doors should be well fitted by maintaining the positive pressure air flow and self closing.
Doors must be limited in number.
• All pipes passing through the walls of the room should be effectively sealed and should be
flush fitting and easily cleaned.
• Gas cylinders should be excluded and all gases should be piped from outside the area.
• Sinks and drains must be excluded from the areas where aseptic procedures are performed
in clean room areas.
• Light sources in clean rooms are fitted with the ceilings to reduce the
collection of the dust and to avoid the disturbance of the air flow pattern
with in the room.
• Non essential switches such as room lighting switches should be
installed outside the clean area.
Personnel and protective clothing
• The main source of contamination of clean areas arises from skin scales
which are released by the operators.
• Personnel selected to work on the preparation of the parenteral products must
be neat and reliable.
• They should be in good health and free from dermatological conditions that
might increase the microbial load.
• Operator -borne contamination can be controlled by limiting the number of
operators in clean area.
• All personnel should be trained for Good Manufacturing Practices(GMP) and
aseptic techniques.
• The operator should wear sterile protective clothing including head wear,
powder free rubber or plastic gloves, a non-fibre shedding facemask and
footwear.
• All protective clothing is designed to prevent the contamination from the body.
• All protective clothing must be sterilized by moist heat sterilization or ethylene
oxide sterilization.
• Fresh sterile clothing should normally be provided each time the person enters
the aseptic area.
Cleaning and disinfection
• Cleaning and disinfection procedures are used for the removal of microbial
and particulate contamination. •
• Cleaning agents are the alkaline detergents, non-ionic and ionic surfactants.
• Different concentration of quarternary ammonium compounds, sodium
hypochloride, ethanol and formaldehyde solutions are used as disinfectants in
cleaning area. •
• Cetrimide or chlorhexidine in 70% alcohol are suitable for use as skin
disinfectants.
Air Supply
• The air supplied to a clean room must be filtered through High Efficiency
Particulate Air (HEPA) filters.
• The HEPA filter must be positioned at the inlet of the clean room and the pre-filter
may be fitted upstream of the HEPA filters to prolong the life of final filter.
• HEPA filters are used in the construction of vertical and horizontal laminar air flow
bench.
• The air velocity at all parts of the filter area has to be about 0.54 m/sec or
(90+20feet/min)..
• Removes the Dioctyphthalate (DOP) particles of size-0.3pm.
• The air filtered from the laminar air flow is claimed to be 99.97% free
from the microbial contamination.
• These filters are supported to provide class 100 air and they should be
certified every 6 to12 months.
• Air quality is evaluated using settle plates, microbial air sampler or by
particle counters
Laminar flow equipment
INTRODUCTION:
• Also called a “Laminar Airflow Hood / Laminar Aseptic Hoods”.
• A Laminar Airflow Hood (LAFH)/ Laminar Aseptic Hoods, or a
workbench, is a primary engineering control device which provides the
following services during aseptic compounding,
1) Clean air to the critical sites (immediate aseptic compounding area),
2) Constant flow of air out of the work area to prevent the entry of room air, and
3) Outward flow of air from the hood that suspends and removes contaminants which
have been introduced in the work area by personnel.
• TYPES:
1. Vertical laminar air flow bench
2. Horizontal laminar air flow bench
High Efficiency Particulate Air (HEPA) Filter.
•High Efficiency Particulate Air (HEPA) Filter is the most
important part of a LAFH.
•The air within the room is taken into this filter and passed
through a pre-filter which removes the gross contaminants (lint,
dust, etc.).
•The air is then blown at a uniform velocity through the hood
and HEPA filter in a unidirectional (laminar flow) manner over
the aseptic area.
•HEPA filter is a particulate filter which traps the airborne
particles and microbes; but allows the gases to pass through.
• HEPA filters should be fitted either at or near to the clean room inlet.
• A pre-filter is fitted upstream of the HEPA filter, thus extending the final
filter's life.
• A fan is also fitted which pumps the air through the filter.
• The filter medium used in HEPA filters 1S made up of pleated fiberglass
paper.
• Parallelly arranged pleats not only increase the filter surface area but also the air
flow through the filter.
• This parallel arrangement of filter medium also allows the filter to retain a
compact volume.
• The filter material is sealed to an aluminium
frame within the filter.
• One side of the filter is protected with a coated
mild steel mesh. HEPA filters provide,
• 1) A high air flow rate,
• 2) A high particulate holding capacity, and
• 3) A low-pressure drop across the filter.
• HEPA filters remove larger, medium, and
smaller particles from the air by inertial
impaction, direct interception, and by
Brownian diffusion, respectively.
• The HEPA filters are least efficient in removing
particles of about 0.3um size.
• However, its efficiency of removing particles is
affected by air velocity and filter packing.
• It removes larger and smaller particles with more
efficiency.
1) Vertical Laminar Airflow Hoods:
• These hoods sweep the filtered air vertically.
• The air passing through HEPA filters merges from the
top and passes downward through the working area.
• When a foreign object comes in between the sterile
object and the HEPA filter, the wind turbulence in the
critical area increases, and foreign contaminants are
carried to the sterile work surface, thus contaminating the
injection port, needle, or syringe.
• For ensuring complete sterility, nothing should pass
behind a sterile object in a horizontal airflow hood; and
in case of vertical airflow hood, nothing should pass
above the sterile object.
• The materials within the compounding work area
interrupt the pattern of air blowing from the HEPA
filter.
1)Horizontal Laminar Airflow Hoods:
• These hoods sweep the filtered air from the back
to the front of the hood.
• An electrical blower draws the contaminated
room air using a pre-filter, to remove gross
contaminants.
• The air after passing through the pre-filter is
accelerated so that a consistent airflow
distribution reaches the final filter (HEPA filter),
present at the back portion of the hood's working
area.
• HEPA filter removes 99.97% of 0.3µ or larger
sized particles, thus removing most of the 0.5µ
or larger sized airborne microorganisms.
Operating Instructions
• It should be placed away from traffic, doors, air vents, or anything that can produce air currents,
to avoid entrance of contaminants.
• It should remain on for 24 hours otherwise, non-filtered, non-sterile air occupies the
compounding work area.
• Before using the LAFH, its interior working surfaces should be disinfected using 70% isopropyl
alcohol and a clean, lint-free cloth.
• Plexiglas sides present in some types of LAFHs, should not be cleaned using alcohol but with warm water
and a germicidal detergent (e.-g.Lysol).
• HEPA filter grill (protective grill) should be cleaned in such a way that it does not get wet.
• Objects essential for aseptic compounding should be placed in the hood.
• Other objects like Paper, pens, labels, or trays should not be placed in this area.
• The operators during compounding should not wear any jewellery on hands or wrists since they
affect the integrity of personnel clothing (gowns and gloves).
• The operators should minimize talking and should cough away from the compounding work
area.
• The operators should avoid or reduce the unnecessary movement within or around the
LAFH to minimize the airflow turbulence.
• Smoking, eating, gum chewing, and drinking are strictly prohibited in the aseptic
environment.
• The objects should be arranged to get full benefit of the laminar air flow.
• Critical items should be placed close to the air source.
• The objects in the horizontal hood should not be placed closer than 3 inches from the
back of the hood (ensuring that nothing should be in direct contact with the filter).
• Testing should be done on a regular basis by qualified personnel.
Uses of Laminar Air Flow.
• It has various applications, especially where an individual clean air environment is
required for smaller items, e.g., particle sensitive electronic devices.
• It is used for special operations in laboratories.
• It can be tailor made to the specific requirements of laboratories and are also used for
general lab work, especially in medical, pharmaceutical, electronic, and industrial
sectors.
Advantages of Laminar Air Flow.
• The sterile area becomes spacious.
• No heat generation.
• Bigger flasks having wide lids can be used.
Limitations of Laminar Air Flow.
• A laminar airflow hood Should remain on for 24 hours. lf it is turned off; it should be
left on for at least 30 minutes for its disinfection before use.
Air flow pattern
• The air flow pattern within the clean room must be carefully regulated
• To avoid generating particles from the clean room floor, walls and operators.
• The general airflow patterns in in clean rooms are,
1. Unidirectional airflow
2. Non-unidirectional airflow
3. Combined airflow
Unidirectional airflow
• Air enters the room through a complete wall or
ceiling of high-efficiency filters. This air will sweep
contamination in a single direction to the exhaust
system on the opposing wall or floor (Fig. 22.5). In
the interests of economy, the exhaust grill may be
fitted low down on the wall. The velocity of the air
is about 0.3 m/s in down flow air from ceiling filters
and 0.45 m/s in cross flow air. These are highly
efficient airflow systems. However, one major
disadvantage of these rooms for pharmaceutical use
is that they are expensive to construct. They also
use much more conditioned air than rooms with
non-unidirectional airflow. This greatly increases
their operating costs. Owing to these factors,
unidirectional airflow clean rooms are seldom used
for pharmaceutical purposes.
 Non-unidirectional airflow systems
• Air enters the clean rooms through filters and diffusers that
are usually located in the ceiling. It exits through outlet ducts
positioned low down on the wall or in the floor at sites remote
from the air inlet (Fig. 40.4). With the use of this system, the
filtered inlet air mixes with and dilutes the contaminated air
within the room. As the clean room air has been previously
heated and cleaned, it can be recirculated to save energy, a
little fresh air being introduced with each air change cycle.
• Various designs of diffuser are used with this ventilation
system. These affect the air movement and the cleanliness of
the rooms. The perforated plate diffuser produces a jet flow of
air directly beneath it. This jet of air will carry contamination
at its edges. However, it does produce high-quality air directly
under the diffuser. It is thus important that production
procedures are located directly below the diffuser. By contrast,
the air released from the bladed diffuser will mix with the
clean room air. This diffuser thus produces a reasonably
constant quality of air throughout the room.
Combined airflow
• In many pharmaceutical clean rooms, it is
common to find that the background area is
ventilated by a non-unidirectional airflow
system. Meanwhile, the critical areas are
supplied with high-quality air from
unidirectional airflow units.
• The combination airflow system is often
selected for pharmaceutical clean room
applications as it:
• image Produces controlled room pressure
• image Separates the manufacturing process from
the general clean room
• image Is cheaper to use.
 Different Sources of Contamination in an Aseptic Area
1) Personnel:
Those supervising, performing, or controlling drug manufacturing are a potential
source of microbial contamination, due to the following reasons:
i) Inadequate training,
ii) Direct contact between the hands and starting materials, primary packaging
materials, and intermediate or bulk products,
iii) Improper hygiene,
iv) Unauthorised personnel entering the production, storage, and product control
areas,
v) Insufficient gowning and protective equipment, and
vi) Eating, drinking, or smoking within the storage and processing areas.
2) Buildings and Facilities:
• These are also important contributors to microbial contamination due to the
following reasons:
1. Inadequate size and organisation of the space, which lead to selection errors
(such as mixups or cross-contamination between consumables, raw materials,
in-process materials, and finished products),
2. Poor filth and pest controls,
3. Rough floors, walls, and ceilings,
4. Absence of air filtration systems,
5. Inadequate lighting and ventilation systems,
6. Poorly located vents, ledges, and drains, and
7. Improper washing, cleaning, toilet, locker facilities, sanitary operation, and
personal cleanliness.
3) Equipment and Utensils:
These are used during processing, holding, transferring and
packaging. They are the common sources of microbial
contamination due to the following reasons
i) Unsuitable design, size, corrosion-causing materials, static
material accumulation, and/or adulteration with lubricants,
coolants, dirt, and sanitizing agents,
ii) Inadequate cleaning and sanitization,
iii) Inefficient cleaning and maintenance due to their designing
iv) Inappropriate calibration and irregular service, and
v) Using defective equipment.
4) Raw Materials:
These are used during production and are considered a potential source of
contamination due to the following reasons:
i. Improper storage and handling, which leads to mix-ups or selection
errors,
ii. Microbial or chemical contamination,
iii. Degradation due to extreme environmental conditions (like heat, cold,
sunlight, moisture, etc.),
iv. Wrong labelling.
v. Incorrect sampling and testing, and
vi. Using materials not meeting the acceptance criteria.
5) Manufacturing Process:
During the manufacturing process, microbial contamination of raw materials,
intermediates or packaging materials can widely occur due to the following
reasons:
i) Absence of facilities required for manufacturing of a single product,
ii) Improper cleaning between batches for minimising the amount of product
changeovers,
iii) Use of an open manufacturing system for exposing the product to the room
environment,
iv) Improper zoning,
v) Lacking an area line clearance (as per the approved procedures) after each
cleaning process and between each batch, and
vi) Lack of cleaning status labelling on all equipment and materials used
within the manufacturing facility.
 Methods of Prevention of Contamination
• The steps by which microbial contamination of products can be prevented in
aseptic areas are discussed below:
1) Personnel: They can take the following measures:
i) Access to production areas by the unauthorised personnel should be restricted,
and only trained ones should be allowed to enter.
ii) Adequate personnel hygiene should be maintained.
iii) The personnel should be given proper and regular training with respect to
hygiene as well to ensure that their activities do not hamper the product
quality.
iv) Personnel entering the manufacturing area should wear protective clothing
(over-garments, hair cover, beard or moustache cover, and overshoes). V)
Personnel should avoid touching with naked hands the exposed products or
any part of equipment in contact with the product.
v) Personnel should avoid touching with naked hands the exposed products or
any part of equipment in contact with the product.
2) Facility Design:
This includes the following measures:
i) In aseptic rooms, the differential air pressures should be higher than the
adjacent controlled areas.
ii) Air filtration and air change rates should be set to attain the defined clean
room class.
iii) Unidirectional (laminar flow) air flow should be maintained over critical
areas at sufficient velocity to sweep particles away from filling/closing area.
iv) Ambient temperature and humidity should not be very high.
v) The ventilated cabinets, RABS (Restricted Access Barrier System), isolators
systems, etc. should be used depending on the facility/product risk
assessment results in order to achieve an absolute or partial barrier to contain
microorganisms at their point of use
vi) The areas of unequal risk are separated by UV air locks and door barriers.
vii) All open-container processing should be performed within the isolator/RABS.
viii) The air pressure of the changing room should be negative with respect to the
manufacturing area corridor, but positive with respect to the external adjacent
areas.
ix) The ventilation dampers, specially designed filters, and other services should
be positioned such that they can be accessed from outside the manufacturing areas
(service voids or service corridors) for maintenance purposes.
X) An impermeable barrier should be used in appropriate areas to prevent cross-
contamination between two zones, such as closed systems, pumped, or vacuum
transfer of materials.
xi) HVAC air distribution components should be used for preventing the
spreading of contaminants generated within the room.
xii) All rooms and surfaces should be maintained and monitored for viable and
non-viable particulates and this facility should be re-certified on a semi-annual
basis. Facility and equipment design cannot eliminate microbial contamination
completely but good risk assessment and consequent hygienic design can reduce
these risks several times.
For example, i) Flow of man and material should be uniform, ii) Equipment
having smooth surfaces of appropriate material can facilitate effective cleaning,
and iii) Closed Material Transfer Systems.
3) Access to Areas:
This includes the following measures:
i) Access to production, packaging, and QC areas by
unauthorised personnel should be restricted.
ii) Personnel should gain access to these areas only via
changıng rooms.
iii) Materials should be accessed via specific routes (generally
air locks).
4) Building Requirements:
This includes the following measures:
i) Smooth, crack-free, and easily cleanable floors, walls, and ceilings should be
used as they facilitate easy and effective cleaning.
ii) Windows or viewing panels should be closed (non-opening), fixed with wall
panels, and sealed to prevent accumulation of dust and microbial contaminants.
iii) The designing of pipe work, ventilation, and light points should be such that
Creation of recesses which are not easily cleanable is avoided.
iv) Sinks of stainless steel should be present within the production areas.
5) Cleaning and Disinfection:
This includes the following measures:
i) Time-to-time cleanliness and disinfection of the areas should be done.
ii) Adequate hygiene should be maintained in every aspect of the drug product
manufacturing.
iii) Cleaning agents of proper grades should be used for minimizing health risks.
iv) Contact time, application, temperature, mechanical action, and the chemistry of
cleaning agents should be considered during the cleaning process.
v)The cleaning agents should not be directly applied on the product.
vi) The cleaning practices should be validated to prove that the process effectively
controls microbial contamination.
6) Utilities:
• This includes the following measures:
i) Water of pharmaceutical grade, microbiologically controlled and
monitored should be used in the manufacturing of products.
ii) Clean and additive-free steam should be used for cleaning and
sanitization of production tools and equipment, and to supply for
autoclaves and humidification.
Clean Area Classification
• The clean or buffer room is the secondary engineering control. It houses the
primary engineering controls (the LAFH, BSC, or CA) where the aseptic
compounding is actually performed.
• Clean room is a specially constructed enclosed area, which contains one or
more clean zones, where the concentration of airborne particles is controlled
using HEPA filters, continuous air circulation, and a physical barrier to non-
filtered (or outside) air.
• Clean rooms establish appropriate environmental levels for airborne
particulates, temperature, humidity, air pressure, and airflow patterns. Clean
rooms are categorized by their constant air quality or class.
• Clean rooms are rated as given in table 4.1:
• Clean rooms are rated as given in table:
• (Lower the classification number, cleaner is the air.)
Clean Room Properties
Class 10,000 (ISO class 7) 10,000 or less particles of 0.5 µ and larger size
exist in a given cubic foot of air.
Class 1,000 (ISO class 6) 1,000 or less particles of 0.5 µ and larger size
exist in a given cubic foot of air.
Class 100 (ISO class 5) 100 or less particles of 0.5 µ and larger size
exist in a given cubic foot of air.
THANK YOU

Weitere ähnliche Inhalte

Was ist angesagt?

Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...Ms. Pooja Bhandare
 
Physicochemical properties of drug molecules
Physicochemical properties of drug moleculesPhysicochemical properties of drug molecules
Physicochemical properties of drug moleculesMahewash Sana Pathan
 
Aseptic area Unit 4 B pharm microbiology
Aseptic area Unit 4 B pharm microbiology Aseptic area Unit 4 B pharm microbiology
Aseptic area Unit 4 B pharm microbiology SanjaySankhala1
 
Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU...
Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU...Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU...
Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU...Ms. Pooja Bhandare
 
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...Ms. Pooja Bhandare
 
Microbiological assay-Principles and methods of different microbiological assay.
Microbiological assay-Principles and methods of different microbiological assay.Microbiological assay-Principles and methods of different microbiological assay.
Microbiological assay-Principles and methods of different microbiological assay.someshwar mankar
 
Study of principle, procedure, merits, demerits and applications of physical,...
Study of principle, procedure, merits, demerits and applications of physical,...Study of principle, procedure, merits, demerits and applications of physical,...
Study of principle, procedure, merits, demerits and applications of physical,...Ms. Pooja Bhandare
 
State of matter and properties of matter (Part-2) (Latent Heat, Vapour pressu...
State of matter and properties of matter (Part-2) (Latent Heat, Vapour pressu...State of matter and properties of matter (Part-2) (Latent Heat, Vapour pressu...
State of matter and properties of matter (Part-2) (Latent Heat, Vapour pressu...Ms. Pooja Bhandare
 
Evaluation of the efficiency of sterilization methods. Sterility indicators
Evaluation of the efficiency of sterilization methods.Sterility indicatorsEvaluation of the efficiency of sterilization methods.Sterility indicators
Evaluation of the efficiency of sterilization methods. Sterility indicatorsMs. Pooja Bhandare
 
Pharmaceutical Engineering: Corrosion
Pharmaceutical Engineering: CorrosionPharmaceutical Engineering: Corrosion
Pharmaceutical Engineering: CorrosionParag Jain
 
pH, BUFFERS & ISOTONIC SOLUTIONS.pptx
pH, BUFFERS & ISOTONIC  SOLUTIONS.pptxpH, BUFFERS & ISOTONIC  SOLUTIONS.pptx
pH, BUFFERS & ISOTONIC SOLUTIONS.pptxBALASUNDARESAN M
 
Complexation and Protein Binding [Part-2] (Method of analysis, Complexation a...
Complexation and Protein Binding [Part-2](Method of analysis, Complexation a...Complexation and Protein Binding [Part-2](Method of analysis, Complexation a...
Complexation and Protein Binding [Part-2] (Method of analysis, Complexation a...Ms. Pooja Bhandare
 
Microbiological Assay of Vitamin & Amino acid Assessment of a New Antibiotic...
Microbiological Assay of  Vitamin & Amino acid Assessment of a New Antibiotic...Microbiological Assay of  Vitamin & Amino acid Assessment of a New Antibiotic...
Microbiological Assay of Vitamin & Amino acid Assessment of a New Antibiotic...Ms. Pooja Bhandare
 
Ideal solubility parameter (solubility of drug part 2)
Ideal solubility parameter (solubility of drug part 2)Ideal solubility parameter (solubility of drug part 2)
Ideal solubility parameter (solubility of drug part 2)Ms. Pooja Bhandare
 
State of matter and properties of matter (Part-8) (Physicochemical propertie...
State of matter and properties  of matter (Part-8)(Physicochemical propertie...State of matter and properties  of matter (Part-8)(Physicochemical propertie...
State of matter and properties of matter (Part-8) (Physicochemical propertie...Ms. Pooja Bhandare
 

Was ist angesagt? (20)

Aseptic area
Aseptic areaAseptic area
Aseptic area
 
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
 
Spreading coefficient
Spreading coefficientSpreading coefficient
Spreading coefficient
 
Physicochemical properties of drug molecules
Physicochemical properties of drug moleculesPhysicochemical properties of drug molecules
Physicochemical properties of drug molecules
 
Aseptic area Unit 4 B pharm microbiology
Aseptic area Unit 4 B pharm microbiology Aseptic area Unit 4 B pharm microbiology
Aseptic area Unit 4 B pharm microbiology
 
Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU...
Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU...Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU...
Preservation of pharmaceutical products using antimicrobial agents. PHARMACEU...
 
Ph, buffers & isotonic solution
Ph, buffers & isotonic solutionPh, buffers & isotonic solution
Ph, buffers & isotonic solution
 
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...
 
Microbiological assay-Principles and methods of different microbiological assay.
Microbiological assay-Principles and methods of different microbiological assay.Microbiological assay-Principles and methods of different microbiological assay.
Microbiological assay-Principles and methods of different microbiological assay.
 
Study of principle, procedure, merits, demerits and applications of physical,...
Study of principle, procedure, merits, demerits and applications of physical,...Study of principle, procedure, merits, demerits and applications of physical,...
Study of principle, procedure, merits, demerits and applications of physical,...
 
State of matter and properties of matter (Part-2) (Latent Heat, Vapour pressu...
State of matter and properties of matter (Part-2) (Latent Heat, Vapour pressu...State of matter and properties of matter (Part-2) (Latent Heat, Vapour pressu...
State of matter and properties of matter (Part-2) (Latent Heat, Vapour pressu...
 
Evaluation of the efficiency of sterilization methods. Sterility indicators
Evaluation of the efficiency of sterilization methods.Sterility indicatorsEvaluation of the efficiency of sterilization methods.Sterility indicators
Evaluation of the efficiency of sterilization methods. Sterility indicators
 
Pharmaceutical Engineering: Corrosion
Pharmaceutical Engineering: CorrosionPharmaceutical Engineering: Corrosion
Pharmaceutical Engineering: Corrosion
 
pH, BUFFERS & ISOTONIC SOLUTIONS.pptx
pH, BUFFERS & ISOTONIC  SOLUTIONS.pptxpH, BUFFERS & ISOTONIC  SOLUTIONS.pptx
pH, BUFFERS & ISOTONIC SOLUTIONS.pptx
 
SPOILAGE (PHARMACY)
SPOILAGE  (PHARMACY)SPOILAGE  (PHARMACY)
SPOILAGE (PHARMACY)
 
Complexation and Protein Binding [Part-2] (Method of analysis, Complexation a...
Complexation and Protein Binding [Part-2](Method of analysis, Complexation a...Complexation and Protein Binding [Part-2](Method of analysis, Complexation a...
Complexation and Protein Binding [Part-2] (Method of analysis, Complexation a...
 
Microbiological Assay of Vitamin & Amino acid Assessment of a New Antibiotic...
Microbiological Assay of  Vitamin & Amino acid Assessment of a New Antibiotic...Microbiological Assay of  Vitamin & Amino acid Assessment of a New Antibiotic...
Microbiological Assay of Vitamin & Amino acid Assessment of a New Antibiotic...
 
Complexation
ComplexationComplexation
Complexation
 
Ideal solubility parameter (solubility of drug part 2)
Ideal solubility parameter (solubility of drug part 2)Ideal solubility parameter (solubility of drug part 2)
Ideal solubility parameter (solubility of drug part 2)
 
State of matter and properties of matter (Part-8) (Physicochemical propertie...
State of matter and properties  of matter (Part-8)(Physicochemical propertie...State of matter and properties  of matter (Part-8)(Physicochemical propertie...
State of matter and properties of matter (Part-8) (Physicochemical propertie...
 

Ähnlich wie Designing of aseptic area, laminar flow equipment: Study of different source of contamination in aseptic area and methods of prevention, clean area classification PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IV Part-1

Designingofasepticarea 191022062759
Designingofasepticarea 191022062759Designingofasepticarea 191022062759
Designingofasepticarea 191022062759Brijesh Pratap Singh
 
Design of aseptic area
Design of aseptic areaDesign of aseptic area
Design of aseptic areaSnehal Patel
 
Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...
Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...
Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...Kiran Shinde
 
cGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptxcGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptxzohaibmaqsoodneutrop
 
Quality Management System (QMS): Premises
Quality Management  System (QMS): PremisesQuality Management  System (QMS): Premises
Quality Management System (QMS): Premisessamahhamed3
 
MANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptxMANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptxdrsriram2001
 
Premises - Part of Good Manufacturing Practices
Premises - Part of Good Manufacturing PracticesPremises - Part of Good Manufacturing Practices
Premises - Part of Good Manufacturing PracticesTeny Thomas
 
Aseptic Process Operation.pptx
Aseptic Process Operation.pptxAseptic Process Operation.pptx
Aseptic Process Operation.pptxObyDulla1
 
Parenteral facilities and control pharmaceutics
Parenteral facilities and control pharmaceuticsParenteral facilities and control pharmaceutics
Parenteral facilities and control pharmaceuticsAffrin Shaik
 
Formulation of parenteral products
Formulation of parenteral productsFormulation of parenteral products
Formulation of parenteral productsD.R. Chandravanshi
 
GMP of ASU Drugs
GMP of ASU DrugsGMP of ASU Drugs
GMP of ASU DrugsAkhtar Ali
 
Microbial contamination
Microbial contamination Microbial contamination
Microbial contamination Rinaldo John
 
Sterile Production Pharmaceuticals.pptx
Sterile Production Pharmaceuticals.pptxSterile Production Pharmaceuticals.pptx
Sterile Production Pharmaceuticals.pptxChittaranjan Das
 
Premises Design Construction And Plant
Premises Design Construction And PlantPremises Design Construction And Plant
Premises Design Construction And PlantPrakashKumar721
 
Sanitary design and construction for food processing
Sanitary design and construction for food processing Sanitary design and construction for food processing
Sanitary design and construction for food processing Aarti Vyas
 
Manufacturing of sterile preparations
Manufacturing of sterile preparationsManufacturing of sterile preparations
Manufacturing of sterile preparationsShruti Tyagi
 

Ähnlich wie Designing of aseptic area, laminar flow equipment: Study of different source of contamination in aseptic area and methods of prevention, clean area classification PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IV Part-1 (20)

Designingofasepticarea 191022062759
Designingofasepticarea 191022062759Designingofasepticarea 191022062759
Designingofasepticarea 191022062759
 
Design of aseptic area
Design of aseptic areaDesign of aseptic area
Design of aseptic area
 
Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...
Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...
Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...
 
cGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptxcGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptx
 
Quality Management System (QMS): Premises
Quality Management  System (QMS): PremisesQuality Management  System (QMS): Premises
Quality Management System (QMS): Premises
 
opthalmics.pptx
opthalmics.pptxopthalmics.pptx
opthalmics.pptx
 
MANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptxMANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptx
 
Premises - Part of Good Manufacturing Practices
Premises - Part of Good Manufacturing PracticesPremises - Part of Good Manufacturing Practices
Premises - Part of Good Manufacturing Practices
 
Aseptic Process Operation.pptx
Aseptic Process Operation.pptxAseptic Process Operation.pptx
Aseptic Process Operation.pptx
 
Parenteral facilities and control pharmaceutics
Parenteral facilities and control pharmaceuticsParenteral facilities and control pharmaceutics
Parenteral facilities and control pharmaceutics
 
Parenteral products ii
Parenteral products   iiParenteral products   ii
Parenteral products ii
 
STERILE Prpn.pptx
STERILE Prpn.pptxSTERILE Prpn.pptx
STERILE Prpn.pptx
 
Formulation of parenteral products
Formulation of parenteral productsFormulation of parenteral products
Formulation of parenteral products
 
GMP of ASU Drugs
GMP of ASU DrugsGMP of ASU Drugs
GMP of ASU Drugs
 
Microbial contamination
Microbial contamination Microbial contamination
Microbial contamination
 
Sterile Production Pharmaceuticals.pptx
Sterile Production Pharmaceuticals.pptxSterile Production Pharmaceuticals.pptx
Sterile Production Pharmaceuticals.pptx
 
Aseptic requirements for parenteral products
Aseptic requirements for parenteral productsAseptic requirements for parenteral products
Aseptic requirements for parenteral products
 
Premises Design Construction And Plant
Premises Design Construction And PlantPremises Design Construction And Plant
Premises Design Construction And Plant
 
Sanitary design and construction for food processing
Sanitary design and construction for food processing Sanitary design and construction for food processing
Sanitary design and construction for food processing
 
Manufacturing of sterile preparations
Manufacturing of sterile preparationsManufacturing of sterile preparations
Manufacturing of sterile preparations
 

Mehr von Ms. Pooja Bhandare

Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...Ms. Pooja Bhandare
 
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptxPharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptxMs. Pooja Bhandare
 
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptxGastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptxMs. Pooja Bhandare
 
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...Ms. Pooja Bhandare
 
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)Ms. Pooja Bhandare
 
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit TestLimt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit TestMs. Pooja Bhandare
 
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...Ms. Pooja Bhandare
 
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptxIntroduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptxMs. Pooja Bhandare
 
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...Ms. Pooja Bhandare
 
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...Ms. Pooja Bhandare
 
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni...
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni...Ms. Pooja Bhandare
 
Cultivation and collections of drugs of natural origin..pptx
Cultivation and collections of drugs of natural origin..pptxCultivation and collections of drugs of natural origin..pptx
Cultivation and collections of drugs of natural origin..pptxMs. Pooja Bhandare
 
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...Ms. Pooja Bhandare
 
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...Ms. Pooja Bhandare
 
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptxPharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptxMs. Pooja Bhandare
 
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5Ms. Pooja Bhandare
 
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...Ms. Pooja Bhandare
 
Principles and methods of different microbiological assay, methods for standa...
Principles and methods of different microbiological assay, methods for standa...Principles and methods of different microbiological assay, methods for standa...
Principles and methods of different microbiological assay, methods for standa...Ms. Pooja Bhandare
 
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...Ms. Pooja Bhandare
 

Mehr von Ms. Pooja Bhandare (20)

Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
 
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptxPharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
 
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptxGastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
 
Dental products.pptx
Dental products.pptxDental products.pptx
Dental products.pptx
 
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
 
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
 
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit TestLimt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
 
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
 
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptxIntroduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
 
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
 
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
 
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni...
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni...
 
Cultivation and collections of drugs of natural origin..pptx
Cultivation and collections of drugs of natural origin..pptxCultivation and collections of drugs of natural origin..pptx
Cultivation and collections of drugs of natural origin..pptx
 
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
 
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
 
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptxPharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
 
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
 
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
 
Principles and methods of different microbiological assay, methods for standa...
Principles and methods of different microbiological assay, methods for standa...Principles and methods of different microbiological assay, methods for standa...
Principles and methods of different microbiological assay, methods for standa...
 
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
 

Kürzlich hochgeladen

AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptxiammrhaywood
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomnelietumpap1
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfSpandanaRallapalli
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinojohnmickonozaleda
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 

Kürzlich hochgeladen (20)

AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choom
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdf
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipino
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 

Designing of aseptic area, laminar flow equipment: Study of different source of contamination in aseptic area and methods of prevention, clean area classification PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IV Part-1

  • 1. PHARMACEUTICAL MICROBIOLOGY (BP303T) Unit-IV Part-1 Designing of aseptic area, laminar flow equipment: Study of different source of contamination in aseptic area and methods of prevention, clean area classification. Name: Ms. Pooja Deepak Bhandare Assistant Professor G H RAISONI UNIVERSITY SCHOOL OF PHARMACY
  • 2. Introduction: • Production of sterile products is carried out in a clean area which has strictly controlled environmental quality of air particles, microbial contamination. • Some pharmaceutical products are not terminally sterilized (Packed, Sealed and Sterilized) such products are meant to be prepared from sterile ingredients and are sterilized by filtration before packing in sterile containers. • For manufacturing of such products strict aseptic measures need to be followed and hence as Aseptic Area becomes an essential part of such manufacturing units. • An aseptic area is a premise in a clean area, designed, constructed, serviced and used with an intention to prevent the microbial contamination of the product
  • 3. • Aseptic techniques are employed to provide protection to ophthalmic and parenteral products by preventing the entry of microbial and particulate contamination. • Prevention of microbial contamination is also required to remove pyrogens and toxic bacterial products. The terminally sterilised products (product sealed in container and then sterilised) are prepared in clean areas: while products not terminally sterilised are prepared under aseptic conditions using sterile materials or are sterilised by filtration before being packed in sterile containers.
  • 4. • Such aseptic products are formulated or prepared in an aseptic area, which is a room within a clean area designed, constructed, serviced, and used for controlling and preventing microbial contamination of the product. • Like sterile medicinal products, vaccines containing dead microorganisms, microbial extracts, or inactivated viruses are also filled in aseptic areas; while live or attenuated vaccines are filled in separate areas. • The sterile production unit and the general manufacturing area within the hospital pharmacy or factory should be located separately. • The sterile production unit should be restricted, i.e., unauthorised personnel should not gain access to this unit.
  • 5. Designing of Aseptic Area • Production of sterile products should be carried out in a clean environment with a limit for the environmental quality of microbial and dust particle contamination. • This limit for contamination is necessary to reduce the product contamination. • The production area is normally divided into • i) The clean-up area, • ii) The compounding area, • iii) The aseptic area, • iv) The quarantine area and • v) The packaging/labelling area.
  • 6. • Flow diagram of aseptic area
  • 7. 1. Clean-up section • The cleaning area has walls and ceilings made up of film coating materials. • Air inside the clean area should be free from dust and microorganisms. • This is ensured through high efficiency (95%) filters. • Air existing in the clean area should be frequently replace (10-15 air changes per hour).
  • 8. 2. Compounding section • This area contains stainless steel cabinets and counters and is involved in the actual compounding. • Unlike aseptic area, maintenance of sterile conditions is not essential, but necessary measures should be adopted to control the dust generated from raw material during weighing and compounding.
  • 9. 3.Aseptic area • In this area, strict control measures should be adopted to avoid contamination of the preparations. • The stainless steel counters and cabinets should be such that they should not allow dirt particles to accumulate. • Mixing and storage of the compounded preparations should be done outside the aseptic area. • The compounded preparations are then transferred to the aseptic area through pipelines where the filling operation is carried out.
  • 10. 4. Quarantine section • This area consists of a store where the in process batches as well as approved batches are stored separately. • This area has limited access and is under the control of a responsible person. • Without the consent of the in charge, other personnel cannot enter into this particular area.
  • 11. 5. Packing and labelling section • In this area, the batches are packed and labelled. • Packing is carried out by packaging machines, while labels are obtained by over printing devices. • At a time, only one product labels are printed. • Parenteral packing plays a vital role in the production of sterile preparations. • Packing should be carried out in such a manner that the sterility of the product is maintained.
  • 12. Floors, walls and ceilings • All clean surfaces including the floor, walls and ceilings must be smooth, easy to clean, disinfected and be constructed to minimize microbial and particulate contamination. • Flexing and non-flexing types of materials are used for construction of floor. • Flexing floor materials are made up of synthetic elastromers of which most commonly used are polyvinylchloride (PVC). PVC flooring is easily repaired, cleaned, relatively cheap and simple. • Non-flexing floors are made of hard inorganic filler substances in a matrix material.
  • 13. • Walls must be made up of non-inflammable or fire resistant material e.g: Stainless steel, glass, enamelled steel, etc. • Generally plaster walls are easily damaged by the impact. • For reduction of fungal growth , 1% of 8- hydroxyquinolone, pentachlorophenol, etc may be added to the paint. • Epoxy resin paints and polyurethane paints are also used to avoid cracking and peeling. • The ceilings are sealed to prevent the entry of microbial contaminants. • Internal fittings such as a cupboards, drawers, shelves, and equipment's must be kept to a minimum.
  • 14. Doors, windows and services • Doors and windows should fit flush with the walls. Windows if required, are solely to provide illumination and are not for ventilation. • Windows should be non-open able. • Doors should be well fitted by maintaining the positive pressure air flow and self closing. Doors must be limited in number. • All pipes passing through the walls of the room should be effectively sealed and should be flush fitting and easily cleaned. • Gas cylinders should be excluded and all gases should be piped from outside the area. • Sinks and drains must be excluded from the areas where aseptic procedures are performed in clean room areas.
  • 15. • Light sources in clean rooms are fitted with the ceilings to reduce the collection of the dust and to avoid the disturbance of the air flow pattern with in the room. • Non essential switches such as room lighting switches should be installed outside the clean area.
  • 16. Personnel and protective clothing • The main source of contamination of clean areas arises from skin scales which are released by the operators. • Personnel selected to work on the preparation of the parenteral products must be neat and reliable. • They should be in good health and free from dermatological conditions that might increase the microbial load. • Operator -borne contamination can be controlled by limiting the number of operators in clean area. • All personnel should be trained for Good Manufacturing Practices(GMP) and aseptic techniques.
  • 17. • The operator should wear sterile protective clothing including head wear, powder free rubber or plastic gloves, a non-fibre shedding facemask and footwear. • All protective clothing is designed to prevent the contamination from the body. • All protective clothing must be sterilized by moist heat sterilization or ethylene oxide sterilization. • Fresh sterile clothing should normally be provided each time the person enters the aseptic area.
  • 18. Cleaning and disinfection • Cleaning and disinfection procedures are used for the removal of microbial and particulate contamination. • • Cleaning agents are the alkaline detergents, non-ionic and ionic surfactants. • Different concentration of quarternary ammonium compounds, sodium hypochloride, ethanol and formaldehyde solutions are used as disinfectants in cleaning area. • • Cetrimide or chlorhexidine in 70% alcohol are suitable for use as skin disinfectants.
  • 19. Air Supply • The air supplied to a clean room must be filtered through High Efficiency Particulate Air (HEPA) filters. • The HEPA filter must be positioned at the inlet of the clean room and the pre-filter may be fitted upstream of the HEPA filters to prolong the life of final filter. • HEPA filters are used in the construction of vertical and horizontal laminar air flow bench. • The air velocity at all parts of the filter area has to be about 0.54 m/sec or (90+20feet/min)..
  • 20. • Removes the Dioctyphthalate (DOP) particles of size-0.3pm. • The air filtered from the laminar air flow is claimed to be 99.97% free from the microbial contamination. • These filters are supported to provide class 100 air and they should be certified every 6 to12 months. • Air quality is evaluated using settle plates, microbial air sampler or by particle counters
  • 21. Laminar flow equipment INTRODUCTION: • Also called a “Laminar Airflow Hood / Laminar Aseptic Hoods”. • A Laminar Airflow Hood (LAFH)/ Laminar Aseptic Hoods, or a workbench, is a primary engineering control device which provides the following services during aseptic compounding, 1) Clean air to the critical sites (immediate aseptic compounding area), 2) Constant flow of air out of the work area to prevent the entry of room air, and 3) Outward flow of air from the hood that suspends and removes contaminants which have been introduced in the work area by personnel.
  • 22. • TYPES: 1. Vertical laminar air flow bench 2. Horizontal laminar air flow bench
  • 23. High Efficiency Particulate Air (HEPA) Filter. •High Efficiency Particulate Air (HEPA) Filter is the most important part of a LAFH. •The air within the room is taken into this filter and passed through a pre-filter which removes the gross contaminants (lint, dust, etc.). •The air is then blown at a uniform velocity through the hood and HEPA filter in a unidirectional (laminar flow) manner over the aseptic area. •HEPA filter is a particulate filter which traps the airborne particles and microbes; but allows the gases to pass through.
  • 24. • HEPA filters should be fitted either at or near to the clean room inlet. • A pre-filter is fitted upstream of the HEPA filter, thus extending the final filter's life. • A fan is also fitted which pumps the air through the filter. • The filter medium used in HEPA filters 1S made up of pleated fiberglass paper. • Parallelly arranged pleats not only increase the filter surface area but also the air flow through the filter. • This parallel arrangement of filter medium also allows the filter to retain a compact volume.
  • 25. • The filter material is sealed to an aluminium frame within the filter. • One side of the filter is protected with a coated mild steel mesh. HEPA filters provide, • 1) A high air flow rate, • 2) A high particulate holding capacity, and • 3) A low-pressure drop across the filter. • HEPA filters remove larger, medium, and smaller particles from the air by inertial impaction, direct interception, and by Brownian diffusion, respectively. • The HEPA filters are least efficient in removing particles of about 0.3um size. • However, its efficiency of removing particles is affected by air velocity and filter packing. • It removes larger and smaller particles with more efficiency.
  • 26. 1) Vertical Laminar Airflow Hoods: • These hoods sweep the filtered air vertically. • The air passing through HEPA filters merges from the top and passes downward through the working area. • When a foreign object comes in between the sterile object and the HEPA filter, the wind turbulence in the critical area increases, and foreign contaminants are carried to the sterile work surface, thus contaminating the injection port, needle, or syringe. • For ensuring complete sterility, nothing should pass behind a sterile object in a horizontal airflow hood; and in case of vertical airflow hood, nothing should pass above the sterile object. • The materials within the compounding work area interrupt the pattern of air blowing from the HEPA filter.
  • 27.
  • 28. 1)Horizontal Laminar Airflow Hoods: • These hoods sweep the filtered air from the back to the front of the hood. • An electrical blower draws the contaminated room air using a pre-filter, to remove gross contaminants. • The air after passing through the pre-filter is accelerated so that a consistent airflow distribution reaches the final filter (HEPA filter), present at the back portion of the hood's working area. • HEPA filter removes 99.97% of 0.3µ or larger sized particles, thus removing most of the 0.5µ or larger sized airborne microorganisms.
  • 29.
  • 30. Operating Instructions • It should be placed away from traffic, doors, air vents, or anything that can produce air currents, to avoid entrance of contaminants. • It should remain on for 24 hours otherwise, non-filtered, non-sterile air occupies the compounding work area. • Before using the LAFH, its interior working surfaces should be disinfected using 70% isopropyl alcohol and a clean, lint-free cloth. • Plexiglas sides present in some types of LAFHs, should not be cleaned using alcohol but with warm water and a germicidal detergent (e.-g.Lysol). • HEPA filter grill (protective grill) should be cleaned in such a way that it does not get wet. • Objects essential for aseptic compounding should be placed in the hood. • Other objects like Paper, pens, labels, or trays should not be placed in this area. • The operators during compounding should not wear any jewellery on hands or wrists since they affect the integrity of personnel clothing (gowns and gloves). • The operators should minimize talking and should cough away from the compounding work area.
  • 31. • The operators should avoid or reduce the unnecessary movement within or around the LAFH to minimize the airflow turbulence. • Smoking, eating, gum chewing, and drinking are strictly prohibited in the aseptic environment. • The objects should be arranged to get full benefit of the laminar air flow. • Critical items should be placed close to the air source. • The objects in the horizontal hood should not be placed closer than 3 inches from the back of the hood (ensuring that nothing should be in direct contact with the filter). • Testing should be done on a regular basis by qualified personnel.
  • 32. Uses of Laminar Air Flow. • It has various applications, especially where an individual clean air environment is required for smaller items, e.g., particle sensitive electronic devices. • It is used for special operations in laboratories. • It can be tailor made to the specific requirements of laboratories and are also used for general lab work, especially in medical, pharmaceutical, electronic, and industrial sectors. Advantages of Laminar Air Flow. • The sterile area becomes spacious. • No heat generation. • Bigger flasks having wide lids can be used. Limitations of Laminar Air Flow. • A laminar airflow hood Should remain on for 24 hours. lf it is turned off; it should be left on for at least 30 minutes for its disinfection before use.
  • 33. Air flow pattern • The air flow pattern within the clean room must be carefully regulated • To avoid generating particles from the clean room floor, walls and operators. • The general airflow patterns in in clean rooms are, 1. Unidirectional airflow 2. Non-unidirectional airflow 3. Combined airflow
  • 34. Unidirectional airflow • Air enters the room through a complete wall or ceiling of high-efficiency filters. This air will sweep contamination in a single direction to the exhaust system on the opposing wall or floor (Fig. 22.5). In the interests of economy, the exhaust grill may be fitted low down on the wall. The velocity of the air is about 0.3 m/s in down flow air from ceiling filters and 0.45 m/s in cross flow air. These are highly efficient airflow systems. However, one major disadvantage of these rooms for pharmaceutical use is that they are expensive to construct. They also use much more conditioned air than rooms with non-unidirectional airflow. This greatly increases their operating costs. Owing to these factors, unidirectional airflow clean rooms are seldom used for pharmaceutical purposes.
  • 35.  Non-unidirectional airflow systems • Air enters the clean rooms through filters and diffusers that are usually located in the ceiling. It exits through outlet ducts positioned low down on the wall or in the floor at sites remote from the air inlet (Fig. 40.4). With the use of this system, the filtered inlet air mixes with and dilutes the contaminated air within the room. As the clean room air has been previously heated and cleaned, it can be recirculated to save energy, a little fresh air being introduced with each air change cycle. • Various designs of diffuser are used with this ventilation system. These affect the air movement and the cleanliness of the rooms. The perforated plate diffuser produces a jet flow of air directly beneath it. This jet of air will carry contamination at its edges. However, it does produce high-quality air directly under the diffuser. It is thus important that production procedures are located directly below the diffuser. By contrast, the air released from the bladed diffuser will mix with the clean room air. This diffuser thus produces a reasonably constant quality of air throughout the room.
  • 36. Combined airflow • In many pharmaceutical clean rooms, it is common to find that the background area is ventilated by a non-unidirectional airflow system. Meanwhile, the critical areas are supplied with high-quality air from unidirectional airflow units. • The combination airflow system is often selected for pharmaceutical clean room applications as it: • image Produces controlled room pressure • image Separates the manufacturing process from the general clean room • image Is cheaper to use.
  • 37.  Different Sources of Contamination in an Aseptic Area 1) Personnel: Those supervising, performing, or controlling drug manufacturing are a potential source of microbial contamination, due to the following reasons: i) Inadequate training, ii) Direct contact between the hands and starting materials, primary packaging materials, and intermediate or bulk products, iii) Improper hygiene, iv) Unauthorised personnel entering the production, storage, and product control areas, v) Insufficient gowning and protective equipment, and vi) Eating, drinking, or smoking within the storage and processing areas.
  • 38. 2) Buildings and Facilities: • These are also important contributors to microbial contamination due to the following reasons: 1. Inadequate size and organisation of the space, which lead to selection errors (such as mixups or cross-contamination between consumables, raw materials, in-process materials, and finished products), 2. Poor filth and pest controls, 3. Rough floors, walls, and ceilings, 4. Absence of air filtration systems, 5. Inadequate lighting and ventilation systems, 6. Poorly located vents, ledges, and drains, and 7. Improper washing, cleaning, toilet, locker facilities, sanitary operation, and personal cleanliness.
  • 39. 3) Equipment and Utensils: These are used during processing, holding, transferring and packaging. They are the common sources of microbial contamination due to the following reasons i) Unsuitable design, size, corrosion-causing materials, static material accumulation, and/or adulteration with lubricants, coolants, dirt, and sanitizing agents, ii) Inadequate cleaning and sanitization, iii) Inefficient cleaning and maintenance due to their designing iv) Inappropriate calibration and irregular service, and v) Using defective equipment.
  • 40. 4) Raw Materials: These are used during production and are considered a potential source of contamination due to the following reasons: i. Improper storage and handling, which leads to mix-ups or selection errors, ii. Microbial or chemical contamination, iii. Degradation due to extreme environmental conditions (like heat, cold, sunlight, moisture, etc.), iv. Wrong labelling. v. Incorrect sampling and testing, and vi. Using materials not meeting the acceptance criteria.
  • 41. 5) Manufacturing Process: During the manufacturing process, microbial contamination of raw materials, intermediates or packaging materials can widely occur due to the following reasons: i) Absence of facilities required for manufacturing of a single product, ii) Improper cleaning between batches for minimising the amount of product changeovers, iii) Use of an open manufacturing system for exposing the product to the room environment, iv) Improper zoning, v) Lacking an area line clearance (as per the approved procedures) after each cleaning process and between each batch, and vi) Lack of cleaning status labelling on all equipment and materials used within the manufacturing facility.
  • 42.  Methods of Prevention of Contamination • The steps by which microbial contamination of products can be prevented in aseptic areas are discussed below: 1) Personnel: They can take the following measures: i) Access to production areas by the unauthorised personnel should be restricted, and only trained ones should be allowed to enter. ii) Adequate personnel hygiene should be maintained. iii) The personnel should be given proper and regular training with respect to hygiene as well to ensure that their activities do not hamper the product quality. iv) Personnel entering the manufacturing area should wear protective clothing (over-garments, hair cover, beard or moustache cover, and overshoes). V) Personnel should avoid touching with naked hands the exposed products or any part of equipment in contact with the product. v) Personnel should avoid touching with naked hands the exposed products or any part of equipment in contact with the product.
  • 43. 2) Facility Design: This includes the following measures: i) In aseptic rooms, the differential air pressures should be higher than the adjacent controlled areas. ii) Air filtration and air change rates should be set to attain the defined clean room class. iii) Unidirectional (laminar flow) air flow should be maintained over critical areas at sufficient velocity to sweep particles away from filling/closing area. iv) Ambient temperature and humidity should not be very high. v) The ventilated cabinets, RABS (Restricted Access Barrier System), isolators systems, etc. should be used depending on the facility/product risk assessment results in order to achieve an absolute or partial barrier to contain microorganisms at their point of use vi) The areas of unequal risk are separated by UV air locks and door barriers.
  • 44. vii) All open-container processing should be performed within the isolator/RABS. viii) The air pressure of the changing room should be negative with respect to the manufacturing area corridor, but positive with respect to the external adjacent areas. ix) The ventilation dampers, specially designed filters, and other services should be positioned such that they can be accessed from outside the manufacturing areas (service voids or service corridors) for maintenance purposes. X) An impermeable barrier should be used in appropriate areas to prevent cross- contamination between two zones, such as closed systems, pumped, or vacuum transfer of materials.
  • 45. xi) HVAC air distribution components should be used for preventing the spreading of contaminants generated within the room. xii) All rooms and surfaces should be maintained and monitored for viable and non-viable particulates and this facility should be re-certified on a semi-annual basis. Facility and equipment design cannot eliminate microbial contamination completely but good risk assessment and consequent hygienic design can reduce these risks several times. For example, i) Flow of man and material should be uniform, ii) Equipment having smooth surfaces of appropriate material can facilitate effective cleaning, and iii) Closed Material Transfer Systems.
  • 46. 3) Access to Areas: This includes the following measures: i) Access to production, packaging, and QC areas by unauthorised personnel should be restricted. ii) Personnel should gain access to these areas only via changıng rooms. iii) Materials should be accessed via specific routes (generally air locks).
  • 47. 4) Building Requirements: This includes the following measures: i) Smooth, crack-free, and easily cleanable floors, walls, and ceilings should be used as they facilitate easy and effective cleaning. ii) Windows or viewing panels should be closed (non-opening), fixed with wall panels, and sealed to prevent accumulation of dust and microbial contaminants. iii) The designing of pipe work, ventilation, and light points should be such that Creation of recesses which are not easily cleanable is avoided. iv) Sinks of stainless steel should be present within the production areas.
  • 48. 5) Cleaning and Disinfection: This includes the following measures: i) Time-to-time cleanliness and disinfection of the areas should be done. ii) Adequate hygiene should be maintained in every aspect of the drug product manufacturing. iii) Cleaning agents of proper grades should be used for minimizing health risks. iv) Contact time, application, temperature, mechanical action, and the chemistry of cleaning agents should be considered during the cleaning process. v)The cleaning agents should not be directly applied on the product. vi) The cleaning practices should be validated to prove that the process effectively controls microbial contamination.
  • 49. 6) Utilities: • This includes the following measures: i) Water of pharmaceutical grade, microbiologically controlled and monitored should be used in the manufacturing of products. ii) Clean and additive-free steam should be used for cleaning and sanitization of production tools and equipment, and to supply for autoclaves and humidification.
  • 51. • The clean or buffer room is the secondary engineering control. It houses the primary engineering controls (the LAFH, BSC, or CA) where the aseptic compounding is actually performed. • Clean room is a specially constructed enclosed area, which contains one or more clean zones, where the concentration of airborne particles is controlled using HEPA filters, continuous air circulation, and a physical barrier to non- filtered (or outside) air. • Clean rooms establish appropriate environmental levels for airborne particulates, temperature, humidity, air pressure, and airflow patterns. Clean rooms are categorized by their constant air quality or class.
  • 52. • Clean rooms are rated as given in table 4.1: • Clean rooms are rated as given in table: • (Lower the classification number, cleaner is the air.) Clean Room Properties Class 10,000 (ISO class 7) 10,000 or less particles of 0.5 µ and larger size exist in a given cubic foot of air. Class 1,000 (ISO class 6) 1,000 or less particles of 0.5 µ and larger size exist in a given cubic foot of air. Class 100 (ISO class 5) 100 or less particles of 0.5 µ and larger size exist in a given cubic foot of air.